Claraphi Advisory Network, LLC Bristol Myers Squibb CO Transaction History

Claraphi Advisory Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$72.62 - $79.98 $2.45 Million - $2.7 Million	33,702 New	33,702 $2.6 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $331,961 - $361,506	-5,362 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$59.34 - $66.74 $318,181 - $357,859	5,362 New	5,362 $339,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $73,732 - $86,201	-1,345 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $62,408 - $90,693	1,345 New	1,345 $75,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Claraphi Advisory Network, LLC with notifications on news.